Delivery Order SPE2DB22D1106-SPE2DB24FEHM1
Award Date 3/28/24
Potential Completion Date 3/29/24
Potential Value $2.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,498.37 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packages of five. The contract is a firm fixed price delivery order with an ultimate completion date of December 5, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency (DLA) awarded a $4,229.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Aprepitant 80 mg capsules on December 15, 2025, with an ultimate completion date of December 16, 2025. This is a non-set-aside, competitively awarded contract for pharmaceutical delivery to support federal medical procurement needs. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsule unit dose 5-count packages, valued at $10,666.78 with a firm fixed price structure. The contract, awarded on December 23, 2025, with an ultimate completion date of December 24, 2025, represents a non-competitive set-aside delivery order executed through AmerisourceBergen's existing indefinite delivery contract vehicle. The point of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $2,505.27 to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (5 count). The contract, executed on December 17, 2025, with an ultimate completion date of December 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in...
- The Defense Logistics Agency awarded a delivery order valued at $9,188.59 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg Capsule Unit Dose packages (5-count) with a firm fixed-price structure. The contract, awarded January 7, 2026, with an ultimate completion date of January 8, 2026, represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $11,086.37 to AmerisourceBergen Drug Corp for the supply of Aprepitant 80 mg capsules in unit dose packaging (six-count). This order was competitively awarded without set-aside designation and carries a firm fixed price contract type, with an ultimate completion date of November 19, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,463.48 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of AMNESTEEM 40 MG CAPSULE 30S, with a period of performance through March 20, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an existing indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00, which serves as the primary vehicle for the company to...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,841.20 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of pharmaceutical products and medical supplies. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp as the prime contractor, which serves as the primary vehicle for the company to deliver a comprehensive...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, in the amount of $4,421.34. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order for $7,584.72 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The delivery order is for the provision of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications as well as medical materials such as syringes, vials, test kits, and...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEHM1Delivery Order
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order (SPE2DB22D1106|SPE2DB24FEHM1) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product APREPITANT 40 MG CAPSULE UD 5S. The $2,741.69 delivery order has a period of performance through March 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA facilities supporting the Department of Defense. This delivery order was not designated as a set-aside contract.
Generated 6/27/24, 9:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 3/28/24 |